| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K71781559 |
| PharmacoGx | BRD-K71781559 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SLC41A1 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | RPL34 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.07 |
| mRNA | MAOA | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | ADAM33 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | SLC44A5 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | KIR3DL2 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | ATP6V1E1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | PLEKHG6 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.07 |
| mRNA | KLF6 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | VAX2 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
